Butamirate Citrate acts directly on the brain's cough center to suppress cough. Butamirate Citrate is safe and non-sedating, and is neither chemically nor pharmacologically related to opium alkaloids. Butamirate Citrate is rapidly and completely absorbed after oral administration. Maximum concentration is reached within 9 hours with the sustained-release tablet. It is extremely protein-bound, and the plasma elimination half-life is about 13 hours. The active metabolites of Butamirate Citrate also have antitussive action.
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Miracit is used to relieve a dry (non-productive) cough. Dry cough may be caused by a recent viral infection. Miracit is also used for pre & post-operative cough, sedation in patients who will undergo surgical procedures, and bronchoscopy. It can be used in the acute cough of any etiology, whooping cough, and cough due to acute lower respiratory tract infections (tracheitis, laryngitis, bronchitis), etc.
Use in adults:
Use in children & adolescents:
Butamirate Citrate 50 mg tablet:
Butamirate Citrate syrup:
Butamirate Citrate pediatric drops:
Side Effects & Overdose Effects
Accidental overdose with Miracit can cause the following symptoms: drowsiness, nausea, vomiting, diarrhoea, loss of balance and hypotension. Standard emergency procedures should be followed: activated charcoal, saline laxatives and standard cardio-respiratory resuscitation.
Tolerance of Miracit is good. Adverse reactions such as rash, nausea, diarrhoea and vertigo have been observed in a few rare cases, resolving after dose reduction or treatment withdrawal.
Butamirate Citrate should not be used during the first trimester of pregnancy. During the remainder of pregnancy, it can be used if indicated by a physician but with caution. As a general rule, for safety reasons, in the absence of data on elimination of the active substance in breast milk, the benefits of Butamirate Citrate administration during breastfeeding should be carefully weighed against the risks.
Miracit suppresses the cough reflex, and therefore the concomitant use with expectorants should be avoided, since it may lead to mucus retention in the airways, which increases the risk of bronchospasm and respiratory infections. If the cough persists for more than 7 days (more than 3 days in children younger than12 years of age), a doctor must be consulted.
Keep away from light and moisture; store below 30°C. Keep all the medicines out of the reach of children.
⚠️Disclaimer:
At ePharma, we’re committed to providing accurate and accessible health information. However, all content is intended for informational purposes only and should not replace medical advice from a qualified physician. Please consult your healthcare provider for personalized guidance. We aim to support, not substitute, the doctor-patient relationship.